Clinical Trial Update: Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL) [Phase 2]

View source ↗

Summary

Phase 2 trial of dichloroacetate (DCA) in previously treated metastatic breast cancer and non-small cell lung cancer was terminated, with results posted in 2016…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Dichloroacetate (dichloroacetate)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Metastatic Breast Cancer, Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-02-12